Randomized Phase III Trial of Sequential Adjuvant Chemoradiotherapy With or Without Erythropoietin Alfa in Patients With High-Risk Cervical Cancer: Results of the NOGGO-AGO Intergroup Study - Concepedia

Concepedia

Publication | Closed Access

Randomized Phase III Trial of Sequential Adjuvant Chemoradiotherapy With or Without Erythropoietin Alfa in Patients With High-Risk Cervical Cancer: Results of the NOGGO-AGO Intergroup Study

43

Citations

11

References

2011

Year

Jens‐Uwe Blohmer, Stefan Paepke, Jalid Sehouli, Dirk Boehmer, M. Kolben, Florian Würschmidt, Karl Ulrich Petry, Rainer Kimmig, Dirk Elling, Christoph Thomssen,

Journal of Clinical Oncology

Abstract

This study confirms that EPO can be added safely to CRT in patients with cervical cancer, but it failed to demonstrate a significant benefit in RFS and OS.

References

	Year	Citations

Page 1